Literature DB >> 15325040

Sero-epidemiological survey of Neospora caninum infection in dogs in north-eastern Italy.

Gioia Capelli1, Stefano Nardelli, Antonio Frangipane di Regalbono, Antonio Scala, Mario Pietrobelli.   

Abstract

Risk factors associated with Neospora caninum seroprevalence in north-eastern Italy in healthy dogs were assessed. Antibodies to N. caninum were found in 10.9% of 707 kennel and owned dogs by a commercial competitive ELISA (VMRD Inc.). All dogs were negative for Leishmania infantum by indirect fluorescent antibody test indicating no cross reactivity or association between the two protozoa in this area. Seroprevalence association with breed and age of dogs and other factors are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325040     DOI: 10.1016/j.vetpar.2004.06.012

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  4 in total

1.  Prevalence of Neospora caninum infection in Sardinian dairy farms (Italy) detected by iscom ELISA on tank bulk milk.

Authors:  A Varcasia; G Capelli; A Ruiu; M Ladu; A Scala; C Bjorkman
Journal:  Parasitol Res       Date:  2005-12-02       Impact factor: 2.289

Review 2.  Epidemiology and control of neosporosis and Neospora caninum.

Authors:  J P Dubey; G Schares; L M Ortega-Mora
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

3.  Prevalence of antibodies against Toxoplasma gondii and Neospora caninum in dogs.

Authors:  Helio Langoni; Felipe Fornazari; Rodrigo Costa da Silva; Elis Talita Monti; Fausto Baptista Villa
Journal:  Braz J Microbiol       Date:  2014-03-10       Impact factor: 2.476

4.  Seroprevalence of Neospora caninum-specific antibodies in German breeding bitches.

Authors:  Rodolfo Villagra-Blanco; Lora Angelova; Theresa Conze; Gereon Schares; Andrea Bärwald; Anja Taubert; Carlos Hermosilla; Axel Wehrend
Journal:  Parasit Vectors       Date:  2018-02-17       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.